Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Aripiprazole + Mood Stabilizer in Bipolar I Disorder
NCT00606229Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jan 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of aripiprazole in bipolar I disorder, sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Young Mania Rating Scale at Day 168. Started Jan 2008; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00606229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00606229.